{
  "timestamp": "2026-02-01T22:54:12.009864",
  "queries": 12,
  "harness_version": "2.0",
  "baseline": {
    "mode": "baseline",
    "timestamp": "2026-02-01T22:59:02.801704",
    "total_queries": 12,
    "successful": 12,
    "failed": 0,
    "suspect": 0,
    "avg_latency_ms": 23362.166666666668,
    "not_found_rate": 0.25,
    "avg_verified_citations": 3.0,
    "avg_unverified_citations": 0.08333333333333333,
    "scotus_coverage": 0.0,
    "en_banc_coverage": 0.0,
    "phase1_trigger_rate": 0.0,
    "avg_candidates_added": 0.0,
    "avg_phase1_latency_ms": 0.0,
    "avg_answer_length": 4468.0,
    "results": [
      {
        "run_id": "9c4430a8-b378-459b-b637-d51bcf2a5610",
        "query_id": "multi_issue_101_112_a",
        "query": "What are the requirements for patent eligibility under Alice 101 and written description under 112(a)?",
        "conversation_id": "eval_multi_issue_101_112_a_1769986452_757f41d4",
        "success": true,
        "generated_at": "2026-02-01T22:54:44.003303",
        "final_answer_text": "### Immediate Answer:\nUnder **Alice 101**, patent eligibility requires that the claims:\n1. Are not directed to a patent-ineligible concept (e.g., abstract ideas, laws of nature, or natural phenomena) (([1] *Bilski v. Kappos*) *Universal Secure Registry LLC v. Apple Inc.*), (([2] *Alice Corp. v. CLS Bank International*) *Diamond v. Diehr*), (([3] *Mayo Collaborative Services v. Prometheus Laboratories, Inc.*) *KANEKA CORPORATION v. XIAMEN KINGDOMWAY*).\n2. If the claims are directed to a patent-in",
        "answer_length": 7682,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 31140,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_multi_issue_101_112_b_1769986484_d38a7a1c",
        "query_id": "multi_issue_101_112_b",
        "query": "When is a software claim both abstract under 101 and lacking enablement under 112?",
        "conversation_id": "eval_multi_issue_101_112_b_1769986484_d38a7a1c",
        "success": true,
        "generated_at": "2026-02-01T22:55:05.518203",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Williamson v. Citrix Online, LLC, Vasudevan Software, Inc. v. Tibco Software, Inc.\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 316,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 20713,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "2f1506f9-0fe6-4ac1-a51d-717c4f0d6227",
        "query_id": "multi_issue_103_112",
        "query": "How does obviousness analysis differ from written description requirements for genus claims?",
        "conversation_id": "eval_multi_issue_103_112_1769986506_b9ed1b17",
        "success": true,
        "generated_at": "2026-02-01T22:55:31.868107",
        "final_answer_text": "## Immediate Answer:\nObviousness analysis and written description requirements for genus claims differ in their focus and purpose. Obviousness analysis under 35 U.S.C. \u00a7 103 evaluates whether the claimed invention as a whole would have been obvious to a person of ordinary skill in the art at the time of the invention, based on the prior art. In contrast, the written description requirement under 35 U.S.C. \u00a7 112, \u00b6 1 ensures that the patent specification adequately demonstrates that the inventor ",
        "answer_length": 8079,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 25520,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "8d90223c-059f-4a02-83b4-7023ad8c2ffd",
        "query_id": "thin_retrieval_rare_doctrine",
        "query": "What is the Therasense materiality standard for inequitable conduct?",
        "conversation_id": "eval_thin_retrieval_rare_doctrine_1769986532_e2f0f41d",
        "success": true,
        "generated_at": "2026-02-01T22:55:53.831162",
        "final_answer_text": "The Therasense materiality standard for inequitable conduct is the \"but-for materiality\" standard. Under this standard, undisclosed prior art is considered material if the U.S. Patent and Trademark Office (PTO) would not have allowed a claim had it been aware of the undisclosed information. The court must assess materiality by applying the preponderance of the evidence standard and giving the claims their broadest reasonable construction. This standard is stricter than the previous \"reasonable e",
        "answer_length": 3879,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 21136,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "ed1b5256-9eb2-498b-b8c3-4d82f631252b",
        "query_id": "thin_retrieval_rare_terms",
        "query": "How does the doctrine of equivalents apply to prosecution history estoppel after Festo?",
        "conversation_id": "eval_thin_retrieval_rare_terms_1769986554_5f913c89",
        "success": true,
        "generated_at": "2026-02-01T22:56:21.005670",
        "final_answer_text": "The doctrine of equivalents allows a patentee to claim infringement for insubstantial alterations to a patented invention that were not literally captured in the patent claims. However, the application of the doctrine is limited by prosecution history estoppel, which prevents a patentee from recapturing subject matter surrendered during prosecution to obtain a patent. The Supreme Court's decision in *Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.*, 535 U.S. 722 (2002) (\"Festo VIII\"), clarif",
        "answer_length": 8255,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 26322,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "2b3ddbac-f859-4170-8cfc-462c5eb8294e",
        "query_id": "thin_retrieval_specific_case",
        "query": "What is the Williamson v. Citrix test for means-plus-function claim construction?",
        "conversation_id": "eval_thin_retrieval_specific_case_1769986581_272ac268",
        "success": true,
        "generated_at": "2026-02-01T22:56:33.318156",
        "final_answer_text": "The Williamson v. Citrix test for determining whether a claim term invokes means-plus-function treatment under 35 U.S.C. \u00a7 112, \u00b6 6 (now \u00a7 112(f)) is as follows:\n\n1. **Essential Inquiry**: The key question is \"whether the words of the claim are understood by persons of ordinary skill in the art to have a sufficiently definite meaning as the name for structure.\" ([1] *WILLIAMSON v. CITRIX ONLINE, LLC*)\n\n2. **Presumption Based on the Use of \"Means\"**:\n   - If the claim term uses the word \"means,\" ",
        "answer_length": 2953,
        "not_found": false,
        "verified_citations": 1,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 1,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 1,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 11485,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_named_case_doctrine_conflict_1769986593_9354d491",
        "query_id": "named_case_doctrine_conflict",
        "query": "Does KSR or Graham provide the correct framework for motivation to combine references?",
        "conversation_id": "eval_named_case_doctrine_conflict_1769986593_9354d491",
        "success": true,
        "generated_at": "2026-02-01T22:56:40.824367",
        "final_answer_text": "AMBIGUOUS QUERY \u2014 MULTIPLE MATCHES FOUND  \nThe provided excerpts include multiple Federal Circuit decisions discussing the frameworks established in *KSR International Co. v. Teleflex Inc.* and *Graham v. John Deere Co.* for determining motivation to combine references. Please specify which case or issue you want addressed:  \n\n- *KSR International Co. v. Teleflex Inc.* (Opinion ID: 4c82cca6-d846-40f9-9a5f-35042df9ab96)  \n- *Graham v. John Deere Co.* (Opinion ID: a4c215a7-a6f3-4d0d-869c-e33ab635c",
        "answer_length": 800,
        "not_found": false,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 6705,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "local_eval_named_case_doctrine_conflict_2_1769986601_8f6d6750",
        "query_id": "named_case_doctrine_conflict_2",
        "query": "When Alice conflicts with Bilski on abstract idea determination, which controls?",
        "conversation_id": "eval_named_case_doctrine_conflict_2_1769986601_8f6d6750",
        "success": true,
        "generated_at": "2026-02-01T22:57:18.176166",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: In Re Ferguson, Powerblock Holdings, Inc. v. Ifit, Inc., In Re Bilski\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 255,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 36550,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "d265ddb9-d648-45e9-949d-a87d67b5d8b7",
        "query_id": "enablement_heavy_1",
        "query": "What amount of experimentation is undue under the Wands factors for biological claims?",
        "conversation_id": "eval_enablement_heavy_1_1769986638_56b6cae5",
        "success": true,
        "generated_at": "2026-02-01T22:57:38.156769",
        "final_answer_text": "The determination of whether the amount of experimentation is \"undue\" under the **Wands factors** for biological claims depends on a case-specific analysis of several factual considerations. The Federal Circuit has consistently emphasized that the inquiry is not a single, simple factual determination but rather a conclusion reached by weighing multiple factors. Below is a detailed explanation based on the provided excerpts:\n\n---\n\n### Immediate Answer:\nThe amount of experimentation is considered ",
        "answer_length": 6669,
        "not_found": false,
        "verified_citations": 0,
        "unverified_citations": 1,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 1
        },
        "total_sources": 1,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 19153,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "a879c8d1-3343-48da-8bcf-a94ccad33810",
        "query_id": "enablement_heavy_2",
        "query": "How do courts apply the full scope of enablement requirement to genus claims covering thousands of species?",
        "conversation_id": "eval_enablement_heavy_2_1769986658_b684e0a8",
        "success": true,
        "generated_at": "2026-02-01T22:58:20.948200",
        "final_answer_text": "Courts apply the full scope of enablement requirement to genus claims by assessing whether the patent's specification enables a person skilled in the art to make and use the full scope of the claimed invention without undue experimentation. This analysis often involves the application of the *Wands* factors, which include considerations such as the breadth of the claims, the predictability of the art, the amount of guidance provided in the specification, and the amount of experimentation require",
        "answer_length": 7647,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 41952,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "1af8435f-a8be-478f-8eda-c37bf1dff2a8",
        "query_id": "obviousness_combine_1",
        "query": "After KSR, what evidence rebuts a prima facie case of obviousness for combining prior art references?",
        "conversation_id": "eval_obviousness_combine_1_1769986701_a12906fe",
        "success": true,
        "generated_at": "2026-02-01T22:58:46.168335",
        "final_answer_text": "Evidence that rebuts a prima facie case of obviousness for combining prior art references includes objective indicia of nonobviousness, such as unexpected results, teaching away in the prior art, commercial success, long-felt but unmet needs, failure of others, and other secondary considerations. This evidence must be considered as part of the overall obviousness determination and cannot be relegated to a secondary role. The Federal Circuit has consistently emphasized that all evidence, includin",
        "answer_length": 6859,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 24373,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "93cf0821-63cc-4cbb-8341-4c42208acbcb",
        "query_id": "obviousness_combine_2",
        "query": "When can an examiner combine three or more prior art references to reject claims as obvious under 103?",
        "conversation_id": "eval_obviousness_combine_2_1769986726_12b6c8c3",
        "success": true,
        "generated_at": "2026-02-01T22:59:02.301221",
        "final_answer_text": "The conditions under which an examiner can combine three or more prior art references to reject claims as obvious under 35 U.S.C. \u00a7 103 are not explicitly addressed in the provided excerpts. NOT FOUND IN PROVIDED OPINIONS.",
        "answer_length": 222,
        "not_found": true,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 15297,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      }
    ]
  },
  "phase1": {
    "mode": "phase1",
    "timestamp": "2026-02-01T23:04:33.794058",
    "total_queries": 12,
    "successful": 12,
    "failed": 0,
    "suspect": 0,
    "avg_latency_ms": 26758.083333333332,
    "not_found_rate": 0.3333333333333333,
    "avg_verified_citations": 2.75,
    "avg_unverified_citations": 0.4166666666666667,
    "scotus_coverage": 0.0,
    "en_banc_coverage": 0.0,
    "phase1_trigger_rate": 0.5833333333333334,
    "avg_candidates_added": 0.4166666666666667,
    "avg_phase1_latency_ms": 469.4166666666667,
    "avg_answer_length": 3288.25,
    "results": [
      {
        "run_id": "local_eval_multi_issue_101_112_a_1769986742_0f9c3835",
        "query_id": "multi_issue_101_112_a",
        "query": "What are the requirements for patent eligibility under Alice 101 and written description under 112(a)?",
        "conversation_id": "eval_multi_issue_101_112_a_1769986742_0f9c3835",
        "success": true,
        "generated_at": "2026-02-01T22:59:20.868631",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**Potentially relevant cases found but not yet indexed:**\n- Walter C. Fiers v. Michel Revel and Pierre Tiollais v. Haruo Sugano, Masami Muramatsu and Tadatsugu Taniguchi\n\nThe ingested opinions do not contain information relevant to your query. Try ingesting additional opinions or refining your search.",
        "answer_length": 335,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 17765,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "local_eval_multi_issue_101_112_b_1769986761_e443c66f",
        "query_id": "multi_issue_101_112_b",
        "query": "When is a software claim both abstract under 101 and lacking enablement under 112?",
        "conversation_id": "eval_multi_issue_101_112_b_1769986761_e443c66f",
        "success": true,
        "generated_at": "2026-02-01T23:00:12.741816",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Williamson v. Citrix Online, LLC, Vasudevan Software, Inc. v. Tibco Software, Inc.\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 316,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 51071,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "60352a2c-55fa-44ea-b9a7-bb520abd78df",
        "query_id": "multi_issue_103_112",
        "query": "How does obviousness analysis differ from written description requirements for genus claims?",
        "conversation_id": "eval_multi_issue_103_112_1769986813_a8793fe7",
        "success": true,
        "generated_at": "2026-02-01T23:00:41.594886",
        "final_answer_text": "## Immediate Answer:\nObviousness analysis under 35 U.S.C. \u00a7 103 focuses on whether the claimed invention would have been obvious to a person of ordinary skill in the art at the time of the invention, considering the prior art. In contrast, the written description requirement under 35 U.S.C. \u00a7 112, \u00b6 1 ensures that the patent specification demonstrates that the inventor was in possession of the claimed invention as of the filing date, particularly by adequately describing the claimed genus and it",
        "answer_length": 7672,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 28025,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 893,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "c60d4dcb-65c8-466c-ba21-c15e7e6331d1",
        "query_id": "thin_retrieval_rare_doctrine",
        "query": "What is the Therasense materiality standard for inequitable conduct?",
        "conversation_id": "eval_thin_retrieval_rare_doctrine_1769986842_6a39d493",
        "success": true,
        "generated_at": "2026-02-01T23:01:13.952024",
        "final_answer_text": "The Therasense materiality standard for inequitable conduct is \"but-for materiality.\" Under this standard, undisclosed prior art or information is considered material if the U.S. Patent and Trademark Office (PTO) would not have allowed a claim had it been aware of the undisclosed information. Specifically, the court must determine whether the PTO would have allowed the claim if it had been aware of the withheld reference or information. The court applies the preponderance of the evidence standar",
        "answer_length": 2612,
        "not_found": false,
        "verified_citations": 4,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 4,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 4,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 31521,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "low_score"
        ],
        "candidates_added": 0,
        "phase1_triggered": true,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "2f5978cf-053a-42f6-8313-f34244c9446c",
        "query_id": "thin_retrieval_rare_terms",
        "query": "How does the doctrine of equivalents apply to prosecution history estoppel after Festo?",
        "conversation_id": "eval_thin_retrieval_rare_terms_1769986874_16fcc746",
        "success": true,
        "generated_at": "2026-02-01T23:01:37.345848",
        "final_answer_text": "The doctrine of equivalents allows a patentee to claim infringement for insubstantial alterations to a patented invention that were not literally captured in the patent claims. However, prosecution history estoppel limits the application of the doctrine of equivalents by preventing a patentee from recapturing subject matter surrendered during the prosecution of the patent. The Supreme Court's decision in *Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.*, 535 U.S. 722 (2002) (\"Festo VIII\"), c",
        "answer_length": 7804,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 22565,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 817,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "c3d4ac2b-0801-4498-a6cd-4dc6c81b9289",
        "query_id": "thin_retrieval_specific_case",
        "query": "What is the Williamson v. Citrix test for means-plus-function claim construction?",
        "conversation_id": "eval_thin_retrieval_specific_case_1769986897_c2aee605",
        "success": true,
        "generated_at": "2026-02-01T23:01:52.576739",
        "final_answer_text": "The Williamson v. Citrix test for determining whether a claim term invokes means-plus-function treatment under 35 U.S.C. \u00a7 112, \u00b6 6 (pre-AIA) or \u00a7 112(f) (post-AIA) is as follows:\n\n1. **Presumption Based on the Use of \"Means\"**: If the claim term uses the word \"means,\" there is a rebuttable presumption that \u00a7 112, \u00b6 6 applies. Conversely, if the claim term does not use the word \"means,\" there is a rebuttable presumption that \u00a7 112, \u00b6 6 does not apply. (([1] *WILLIAMSON v. CITRIX ONLINE, LLC*) *R",
        "answer_length": 3978,
        "not_found": false,
        "verified_citations": 2,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 2,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 2,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 14397,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 1563,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_named_case_doctrine_conflict_1769986913_d922fd5c",
        "query_id": "named_case_doctrine_conflict",
        "query": "Does KSR or Graham provide the correct framework for motivation to combine references?",
        "conversation_id": "eval_named_case_doctrine_conflict_1769986913_d922fd5c",
        "success": true,
        "generated_at": "2026-02-01T23:02:11.282536",
        "final_answer_text": "AMBIGUOUS QUERY \u2014 MULTIPLE MATCHES FOUND  \nThe provided excerpts include multiple Federal Circuit decisions discussing the frameworks established in *KSR International Co. v. Teleflex Inc.* and *Graham v. John Deere Co.* for motivation to combine references. Please specify which case or issue you want addressed:  \n- *KSR International Co. v. Teleflex Inc.* (Opinion ID: 4c82cca6-d846-40f9-9a5f-35042df9ab96)  \n- *Graham v. John Deere Co.* (Opinion ID: a4c215a7-a6f3-4d0d-869c-e33ab635c298)  \n- Othe",
        "answer_length": 702,
        "not_found": false,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 17904,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "local_eval_named_case_doctrine_conflict_2_1769986931_a05af3ba",
        "query_id": "named_case_doctrine_conflict_2",
        "query": "When Alice conflicts with Bilski on abstract idea determination, which controls?",
        "conversation_id": "eval_named_case_doctrine_conflict_2_1769986931_a05af3ba",
        "success": true,
        "generated_at": "2026-02-01T23:03:01.756746",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: In Re Ferguson, Powerblock Holdings, Inc. v. Ifit, Inc., In Re Bilski\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 255,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 49672,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "c1700168-9ffc-4edf-ab58-eaf473c396d4",
        "query_id": "enablement_heavy_1",
        "query": "What amount of experimentation is undue under the Wands factors for biological claims?",
        "conversation_id": "eval_enablement_heavy_1_1769986982_11932a07",
        "success": true,
        "generated_at": "2026-02-01T23:03:25.641993",
        "final_answer_text": "The amount of experimentation that is considered \"undue\" under the Wands factors for biological claims depends on a case-specific analysis of several factual considerations. The Federal Circuit has consistently emphasized that whether experimentation is undue is not a single, simple factual determination but rather a conclusion reached by weighing multiple factors. These factors, known as the Wands factors, include:\n\n1. **The quantity of experimentation necessary**  \n2. **The amount of direction",
        "answer_length": 4570,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 2,
        "tier_counts": {
          "STRONG": 5,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 2
        },
        "total_sources": 7,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 23046,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "low_score"
        ],
        "candidates_added": 0,
        "phase1_triggered": true,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "5b99ffea-c0a1-4019-a0c5-d78016cd84d5",
        "query_id": "enablement_heavy_2",
        "query": "How do courts apply the full scope of enablement requirement to genus claims covering thousands of species?",
        "conversation_id": "eval_enablement_heavy_2_1769987006_eb244f93",
        "success": true,
        "generated_at": "2026-02-01T23:03:47.507164",
        "final_answer_text": "Courts apply the full scope of enablement requirement to genus claims by assessing whether the patent specification enables a person of ordinary skill in the art to make and use the full scope of the claimed genus without undue experimentation. This analysis often involves evaluating the breadth of the claims, the predictability of the field, the guidance provided in the specification, and the amount of experimentation required. Below is a detailed explanation based on the provided excerpts:\n\n1.",
        "answer_length": 6744,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 21027,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "3f196aa6-ecc5-4372-97b6-d4a4b51f1b3a",
        "query_id": "obviousness_combine_1",
        "query": "After KSR, what evidence rebuts a prima facie case of obviousness for combining prior art references?",
        "conversation_id": "eval_obviousness_combine_1_1769987028_af0ca04a",
        "success": true,
        "generated_at": "2026-02-01T23:04:13.501703",
        "final_answer_text": "## Immediate Answer:\nEvidence that rebuts a prima facie case of obviousness for combining prior art references includes unexpected results, teaching away in the prior art, lack of motivation to combine, and secondary considerations such as commercial success, long-felt but unmet needs, and failure of others. Courts require that all evidence, including rebuttal evidence, be considered collectively before determining obviousness. ([1] *TRANSOCEAN OFFSHORE DEEPWATER DRILLING, INC. V. MAERSK DRILLIN",
        "answer_length": 4246,
        "not_found": false,
        "verified_citations": 2,
        "unverified_citations": 3,
        "tier_counts": {
          "STRONG": 1,
          "MODERATE": 1,
          "WEAK": 0,
          "UNVERIFIED": 3
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 25163,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 1178,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "0882f979-9ac6-4209-8f18-30121fc14134",
        "query_id": "obviousness_combine_2",
        "query": "When can an examiner combine three or more prior art references to reject claims as obvious under 103?",
        "conversation_id": "eval_obviousness_combine_2_1769987054_a33695c2",
        "success": true,
        "generated_at": "2026-02-01T23:04:33.293246",
        "final_answer_text": "The provided excerpts do not explicitly address the specific conditions under which an examiner may combine three or more prior art references to reject claims as obvious under 35 U.S.C. \u00a7 103. NOT FOUND IN PROVIDED OPINIONS.",
        "answer_length": 225,
        "not_found": true,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 18941,
        "augmentation_used": {
          "decompose": true,
          "embeddings": false
        },
        "triggers": [
          "multi_issue"
        ],
        "candidates_added": 1,
        "phase1_triggered": true,
        "phase1_latency_ms": 1182,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      }
    ]
  },
  "comparison": {
    "baseline": {
      "total_queries": 12,
      "successful": 12,
      "avg_latency_ms": 23362.166666666668,
      "not_found_rate": 0.25,
      "avg_verified_citations": 3.0,
      "scotus_coverage": 0.0
    },
    "phase1": {
      "total_queries": 12,
      "successful": 12,
      "avg_latency_ms": 26758.083333333332,
      "not_found_rate": 0.3333333333333333,
      "avg_verified_citations": 2.75,
      "scotus_coverage": 0.0,
      "phase1_trigger_rate": 0.5833333333333334,
      "avg_candidates_added": 0.4166666666666667
    },
    "deltas": {
      "latency_delta_ms": 3395.9166666666642,
      "not_found_delta": 0.08333333333333331,
      "verified_citations_delta": -0.25,
      "scotus_coverage_delta": 0.0
    },
    "improvements": {
      "reduced_not_found": false,
      "more_verified_citations": false,
      "better_scotus_coverage": true
    }
  }
}